Abbott Laboratories hit a new 52-week high, surpassing its previous peak of $136.99, which the company achieved on February ...

Abbott Laboratories (NYSE:ABT) shares closed flat at $135.87 on Thursday, after gaining for six straight sessions. The ...

Abbott Laboratories's ABT short percent of float has risen 21.7% since its last report. The company recently reported that it ...

Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...

Gregg LoCascio, Michael Glick, Tracie Bryant and their team at Kirkland & Ellis secured a defense verdict in California state ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures and sells healthcare products worldwide. It is set to report its Q1 2025 earnings on April 16. Wall Street analysts expect the company ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

A new awareness campaign from Abbott highlights a major sticking point in diabetes management: the harmful impact of societal ...